Literature DB >> 29475732

The Time Is Ripe for Somatic Genome Editing: NIH Program to Strengthen Translation.

Boris Fehse1, Ulrike Abramowski-Mock2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29475732      PMCID： PMC5911638          DOI： 10.1016/j.ymthe.2018.02.005

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  22 in total

1.  Ligation-independent cloning (LIC) assembly of TALEN genes.

Authors:  Jonathan L Schmid-Burgk; Tobias Schmidt; Veit Hornung
Journal:  Methods Mol Biol       Date:  2015

2.  CRISPR gene-editing tested in a person for the first time.

Authors:  David Cyranoski
Journal:  Nature       Date:  2016-11-24       Impact factor: 49.962

3.  Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.

Authors:  Giedrius Gasiunas; Rodolphe Barrangou; Philippe Horvath; Virginijus Siksnys
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

4.  Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain.

Authors:  Y G Kim; J Cha; S Chandrasegaran
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

5.  Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease.

Authors:  P Rouet; F Smih; M Jasin
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

7.  RNA-guided human genome engineering via Cas9.

Authors:  Prashant Mali; Luhan Yang; Kevin M Esvelt; John Aach; Marc Guell; James E DiCarlo; Julie E Norville; George M Church
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

8.  Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells.

Authors:  Waseem Qasim; Hong Zhan; Sujith Samarasinghe; Stuart Adams; Persis Amrolia; Sian Stafford; Katie Butler; Christine Rivat; Gary Wright; Kathy Somana; Sara Ghorashian; Danielle Pinner; Gul Ahsan; Kimberly Gilmour; Giovanna Lucchini; Sarah Inglott; William Mifsud; Robert Chiesa; Karl S Peggs; Lucas Chan; Farzin Farzeneh; Adrian J Thrasher; Ajay Vora; Martin Pule; Paul Veys
Journal:  Sci Transl Med       Date:  2017-01-25       Impact factor: 17.956

Review 9.  The Heroes of CRISPR.

Authors:  Eric S Lander
Journal:  Cell       Date:  2016-01-14       Impact factor: 41.582

10.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140
View more
  1 in total

1.  A mutation-independent CRISPR-Cas9-mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency.

Authors:  Lili Wang; Yang Yang; Camilo Breton; Peter Bell; Mingyao Li; Jia Zhang; Yan Che; Alexei Saveliev; Zhenning He; John White; Caitlin Latshaw; Chenyu Xu; Deirdre McMenamin; Hongwei Yu; Hiroki Morizono; Mark L Batshaw; James M Wilson
Journal:  Sci Adv       Date:  2020-02-12       Impact factor: 14.136
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.